Cargando…
Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis
Tuberculosis (TB) has been a transmittable human disease for many thousands of years, and M. tuberculosis is again the number one cause of death worldwide due to a single infectious agent. The intense 6- to 10-month process of multi-drug treatment, combined with the adverse side effects that can run...
Autores principales: | Abreu, Rodrigo, Giri, Pramod, Quinn, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396704/ https://www.ncbi.nlm.nih.gov/pubmed/32849525 http://dx.doi.org/10.3389/fimmu.2020.01553 |
Ejemplares similares
-
Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
por: Kim, Jae-Sung, et al.
Publicado: (2020) -
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
por: Guler, Reto, et al.
Publicado: (2021) -
Morphoproteomic-Guided Host-Directed Therapy for Tuberculosis
por: Brown, Robert E., et al.
Publicado: (2017) -
Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
por: Ndlovu, Hlumani, et al.
Publicado: (2016) -
Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis
por: Krug, Stefanie, et al.
Publicado: (2021)